Detection of DNA methylation adducts in Hodgkin's disease patients treated with procarbazine

References

• Bianchini F., Wild C. P. 7-Methyldeoxyguanosine as a marker of exposure to environmental methylating agents. Toxicology Letters 1994a; 72: 175–184
   PubMed Web of Science ®Google Scholar
• Bianchini F., Wild C. P. Comparison of 7-medG formation in white blood cells, her and target organs in rats treated with methylating carcinogens. Carcinogenesis 1994b; 15: 1137–1141
   PubMed Web of Science ®Google Scholar
• Bianchini F., Montesano R., Shuker D. E. G., Cuzck J., Wild C. P. Quantification of 7-methyldeoxyguanosine using immunoaffinity purification and HPLC with electrochemical detection. Carcinogenesis 1993; 14: 1677–1682
   PubMed Web of Science ®Google Scholar
• Bofetta P., Kaloor J. M. Secondary malignancies following cancer chemotherapy. Acta Oncologica 1994; 33: 591–598
   PubMed Web of Science ®Google Scholar
• Carde P. Chemotherapy of Hodgkin's disease. Nouvelle Revue Francais d'Hematologie 1990; 32: 169–173
   PubMedGoogle Scholar
• Chakravarn D., Ibeanu G. C., Tano K., Mitra S. Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glucosylase. Journal of Biological Chemistry 1991; 266: 15710–15715
   PubMed Web of Science ®Google Scholar
• Dumenco L. L., Allay E., Norton K., Gerson S. L. The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanineDNA alkyltransferase. Science 1993; 259: 219–222
   PubMed Web of Science ®Google Scholar
• Fong L. Y. Y., Jensen D. E., Magee P. N. DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylintrosourea. Carcinogenesis 1990; 11: 411–417
   PubMed Web of Science ®Google Scholar
• Fong L. Y. Y., Bevill R. F., Thurmon J. C., Magee P. N. DNA adduct dosimetry and DNA repair in rats and pigs given repeated doses of procarbazine under conditions of carcinogenicity and human cancer chemotherapy respectively. Carcinogenesis 1992; 13: 2153–2159
   PubMed Web of Science ®Google Scholar
• Jelink J., Kleibel K., Dexter T. M., Margison G. P. Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis 1988; 9: 81–87
   PubMed Web of Science ®Google Scholar
• Lee I. P., Dixon R. L. Mutagenicity, carcinogenicity and teratogeniclty of procarbazine. Mutation Research 1978; 55: 1–14
   PubMedGoogle Scholar
• Lee S. M., Thatcher N., Margison G. P. O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. Cancer Research 1991; 51: 619–623
   PubMed Web of Science ®Google Scholar
• Iee S. M., Margison G. P., Thatcher N., O'Connor P. J., Cooper D. P. Formation and loss of O6-methyldeoxyguanosine in human leukocyte DNA following sequential DTIC and fotemustine chemotherapy. British Journal of Cancer 1994; 69: 53–57
   Web of Science ®Google Scholar
• Loeb L. A., Preston B. D., Snow E. T., Scheaper R. M. Apurinic sites as common intermediates in mutagenesis. Mechanisms of DNA Damage and Repair, M. G. Simic, L. Grossman, A. C. Liton. Plenum Publishing Corp., New York 1985; 341–347
   Google Scholar
• Meer L., Schold S. C., Kleihues P. Inhibition of the hepatic O6-alkylguanine DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochemical Pharmacology 1989; 38: 929–934
   PubMed Web of Science ®Google Scholar
• Morten J. E. N., Margison G. P. Increased O6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents. Carcinogenesis 1988; 9: 45–49
   PubMed Web of Science ®Google Scholar
• Mustonen R., Forsti A., Hietanen P., Hemminki K. Measurement by 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines. Carcinogenesis 1991; 12: 1423–1431
   PubMed Web of Science ®Google Scholar
• Pegg A. E. Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Investigation 1990; 2: 223–231
   Google Scholar
• Pegg A. E. Mammalian O6-alkylguanineDNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Research 1990; 50: 6119–6129
   PubMed Web of Science ®Google Scholar
• Prough R. A., Tweede D. J. Procarbazine. Metabolism and Action of Anti-Cancer Drugs, G. Powis, R. A. Prough. Taylor & Francis, New York 1988; 29–47
   Google Scholar
• Sagher D., Karrison T, Schwartz J. L., Larson R., Meier P., Strauss B. Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlyrnphocytic leukemia. Cancer Research 1988; 48: 3084–3089
   PubMed Web of Science ®Google Scholar
• Singer B., Grunberger D. Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York & London 1983
   Google Scholar
• Soulitis V. L., Kyrtopoulos S. A. A novel, sensitive assay for O6-methyl and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA alkyltransferase in compeition with an oligonucleotide containing O6-methylguanine. Cancer Research 1989; 49: 6996–7001
   Web of Science ®Google Scholar
• Souliotis V. L., Kaila S., Boussiotis V. A., Pangalis G. A., Kyrtopoulos S. A. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Cancer Research 1990; 50: 2759–2764
   PubMed Web of Science ®Google Scholar
• Soulions V. L., Boussiotis V. A., Pangalis G. A., Kyrtopoulos S. A. In vivo formation and repair of O6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. Carcinogenesis 1991; 12: 285–288
   PubMed Web of Science ®Google Scholar
• Souliotls V. L., Valvanis C., Boussiotis V. A., Pangalis G. A., Kyrtopoulos S. A. Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine. Carcinogenesis 1994; 15: 1675–1680
   PubMed Web of Science ®Google Scholar
• Umbenhauer D., Wild C. P., Montesano R., Saffhll R., Bone J. M., Huh N., Kirstein U., Thomale J., Rajewsky M. F., Lu S. H. O6-Methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. International Journal of Cancer 1985; 36: 661–665
   PubMed Web of Science ®Google Scholar
• Valavanis C, Souliotis V. L., Kyrtopoulos S. A. Differential effects of procarbazine and methylnitrososurea on the accumulation of O6-methylguanine and the depletion and recovery of O6-alkylguanine-DNA alkyltransferase in rat tissues. Carcinogenesis 1994; 15: 1681–1688
   PubMed Web of Science ®Google Scholar
• van Delft J. H. M., van den Ende A. M. C., Keizer H. J., Ouwerkerk J., Baan R. A. Determination of N7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazine. Carcinogenesis 1992; 13: 1257–1259
   PubMed Web of Science ®Google Scholar
• Wiestler O., Kleihues P., Rice J., Ivankovich S. DNA methylation in maternal, fetal, and neonatal rat tissues following perinatal administration of procarbazine. Journal of Cancer Research and Clinical Oncology 1984; 108: 56–59
   PubMed Web of Science ®Google Scholar